Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical

news-medicalApril 01, 2017

Tag: Lymphomas

PharmaSources Customer Service